Financial News

My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innoviva, Inc. - Common Stock (NQ:INVA)

17.48 -0.18 (-0.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Innoviva, Inc. - Common Stock

< Previous 1 2 3 Next >
Beyond The Numbers: 5 Analysts Discuss Innoviva Stock
 
Via Benzinga
Innoviva Inc (NASDAQ:INVA): A Prime Candidate for Value Investors Seeking Undervalued Stocks
Discover Innoviva (INVA), a value stock with strong fundamentals. It trades below intrinsic value, boasts a healthy balance sheet, and has promising growth prospects in biopharma. 
Via Chartmill
Innoviva Inc (NASDAQ:INVA) Recognized as a "Decent Value" Stock with Strong Valuation and Growth Potential
Innoviva (INVA) is a value stock with strong valuation metrics, solid financial health, and growth potential, making it an attractive pick for value investors. 
Via Chartmill
Expert Outlook: Innoviva Through The Eyes Of 4 Analysts
 
Via Benzinga
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday
 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections
 
Via Benzinga
Innoviva (INVA) Q2 Sales Jump 64%
Via The Motley Fool
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Rep. George Whitesides Has Sold Up to $5.18M Worth Of Innoviva Stock: Here's What You Should Know
 
Via Benzinga
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
US Stock: Innoviva
Innoviva Incorporated is a healthcare focused asset management company. The Company intends to participate in the development, commercialization, and financial management of bio-pharmaceuticals. 
Via Talk Markets
Topics Stocks / Equities
What 4 Analyst Ratings Have To Say About Innoviva
 
Via Benzinga
Innoviva Earnings Perspective: Return On Capital Employed
 
Via Benzinga
INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024
INVA stock results show that Innoviva missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher. 
Via InvestorPlace
3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge
Discover three high-growth stock picks set for unprecedented surges in the metals, marine transportation, and pharmaceutical industries. 
Via InvestorPlace
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products. 
Via Benzinga
3 Under-$20 Stocks That Could Make You a Fortune
Discover three under-$20 stocks that could make a fortune in the pharmaceuticals, entertainment, and application software industries. 
Via InvestorPlace
INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024
INVA stock results show that Innoviva beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month. 
Via InvestorPlace
Chart Of The Day: Innoviva - Individual Investor Favorite
100% technical buy signals 14 new highs and up 12.87% in the last month 36.40+ Weighted Alpha 
Via Talk Markets
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. 
Via InvestorPlace
AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter
 
Via Benzinga
Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga
Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories
Benzinga Elon Musk Drops Bombshell: US Intel Agencies Were Reading Your Twitter DMs 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback